Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Baker, J. Balls, C. Regnard, A. Pridie (2007)
Cervical intrathecal analgesia for head and neck/upper limb cancer pain: six case reportsPalliative Medicine, 21
Tomomi Fujii, T. Nagaro, S. Tsubota, K. Takechi, N. Higaki, Toshihiro Yorozuya (2010)
Case reports: management of intractable upper extremity pain with continuous subarachnoid block at the low cervical level without impairment of upper extremity function.Anesthesia and analgesia, 110 6
Brogan (2010)
Intervention therapies for the management of cancer painJ Support Oncol, 8
S. Brogan, Natalie Winter, A. Okifuji (2015)
Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient SatisfactionRegional Anesthesia & Pain Medicine, 40
S. Hassenbusch, J. Paice, R. Patt, M. Bedder, G. Bell (1997)
Clinical realities and economic considerations: economics of intrathecal therapy.Journal of pain and symptom management, 14 3 Suppl
C. Perruchoud, S. Eldabe, A. Durrer, M. Bovy, Morag Brookes, Grace Madzinga, F. Garner, A. Batterham, C. Menoud, M. Jacobs, A. Gulve, E. Buchser (2011)
Effects of flow rate modifications on reported analgesia and quality of life in chronic pain patients treated with continuous intrathecal drug therapy.Pain medicine, 12 4
V. Patel, L. Manchikanti, V. Singh, D. Schultz, S. Hayek, H. Smith (2009)
Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain.Pain physician, 12 2
A. Gulati, V. Puttanniah, J. Hung, V. Malhotra (2014)
Considerations for Evaluating the Use of Intrathecal Drug Delivery in the Oncologic PatientCurrent Pain and Headache Reports, 18
B. Bruel, A. Burton (2016)
Intrathecal Therapy for Cancer-Related PainPain Medicine: The Official Journal of the American Academy of Pain Medicine, 17
Dagmar Westerling (2014)
EUROPEAN PERSPECTIVES ON PAIN AND PALLIATIVE CARE Pain and Other Symptoms in Cancer Survivors
Michael Bottros, P. Christo (2014)
Current perspectives on intrathecal drug deliveryJournal of Pain Research, 7
G. Bhatia, M. Lau, Katharine Koury, P. Gulur (2013)
Intrathecal Drug Delivery (ITDD) systems for cancer painF1000Research, 2
T. Deer, M. Serafini, E. Buchser, F. Ferrante, S. Hassenbusch (2002)
Intrathecal Bupivacaine for Chronic Pain: A Review of Current KnowledgeNeuromodulation: Technology at the Neural Interface, 5
(1990)
World Health Organization Expert Committee. Cancer pain relief and palliative care
S. Mercadante, Giuseppe Intravaia, P. Villari, P. Ferrera, Salvatore Riina, F. David, S. Mangione (2007)
Intrathecal Treatment in Cancer Patients Unresponsive to Multiple Trials of Systemic OpioidsThe Clinical Journal of Pain, 23
S. Karver, Jessalyn Berger (2010)
The challenges of treating patients with cancer pain.The journal of supportive oncology, 8 6
T. Deer, J. Prager, R. Levy, J. Rathmell, E. Buchser, A. Burton, D. Caraway, M. Cousins, J. Andrés, S. Diwan, Michael Erdek, E. Grigsby, M. Huntoon, M. Jacobs, P. Kim, Krishna Kumar, M. Leong, Liong Liem, Gladstone II, S. Panchal, R. Rauck, M. Saulino, B. Sitzman, P. Staats, M. Stanton‐Hicks, L. Stearns, M. Wallace, K. Willis, W. Witt, T. Yaksh, N. Mekhail (2012)
Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert PanelNeuromodulation: Technology at the Neural Interface, 15
(2015)
Ef fi cacy of an intrathecal multidrug infusion for pain control in older adults and in end - stage malignancies : a report of three cases
H. Hettiarachchi, Ying Hsu, Timothy Harris, Richard Penn, A. Linninger (2011)
The Effect of Pulsatile Flow on Intrathecal Drug Delivery in the Spinal CanalAnnals of Biomedical Engineering, 39
Bhatia (2013)
Intrathecal drug delivery(ITDD) systems for cancer painVersion 4 F1000Res, 2
E. Smith, Celia Bridges, Grace Kanzawa, Robert Knoerl, J. Kelly, Anna Berezovsky, C. Woo (2014)
Cancer Treatment-Related Neuropathic Pain Syndromes—Epidemiology and Treatment: An UpdateCurrent Pain and Headache Reports, 18
T. Smith, P. Coyne, P. Staats, T. Deer, L. Stearns, R. Rauck, R. Boortz-Marx, E. Buchser, E. Catalá, D. Bryce, M. Cousins, G. Pool (2005)
An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).Annals of oncology : official journal of the European Society for Medical Oncology, 16 5
P. Glare, P. Davies, Esmé Finlay, A. Gulati, D. Lemanne, N. Moryl, K. Oeffinger, J. Paice, M. Stubblefield, K. Syrjala (2014)
Pain in cancer survivors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 16
World Health Organization Technical Report Series, 804
J. Pope, T. Deer (2015)
Intrathecal drug delivery for pain: a clinical guide and future directions.Pain management, 5 3
E. Krames (1993)
Intrathecal infusional therapies for intractable pain: patient management guidelines.Journal of pain and symptom management, 8 1
Westerling (2014)
Pain and other symptoms in cancer survivorsJ Pain Palliat Care Pharmacother, 28
S. Hayek, T. Deer, J. Pope, S. Panchal, V. Patel (2011)
Intrathecal therapy for cancer and non-cancer pain.Pain physician, 14 3
V. Singh, L. Manchikanti, Ramsin Benyamin, S. Helm, J. Hirsch (2009)
Percutaneous lumbar laser disc decompression: a systematic review of current evidence.Pain physician, 12 3
J. Paice (2011)
Chronic treatment-related pain in cancer survivorsPAIN, 152
Sean Flack, C. Bernards (2010)
Cerebrospinal Fluid and Spinal Cord Distribution of Hyperbaric Bupivacaine and Baclofen during Slow Intrathecal Infusion in PigsAnesthesiology, 112
C. Bernards (2006)
Cerebrospinal Fluid and Spinal Cord Distribution of Baclofen and Bupivacaine during Slow Intrathecal Infusion in PigsAnesthesiology, 105
H. Smith, T. Deer, P. Staats, V. Singh, N. Sehgal, Harold Cordner (2008)
Intrathecal drug delivery.Pain physician, 11 2 Suppl
T. Deer, J. Pope, S. Hayek, A. Bux, E. Buchser, S. Eldabe, J. Andrés, Michael Erdek, D. Patin, J. Grider, D. Doleys, M. Jacobs, T. Yaksh, L. Poree, M. Wallace, J. Prager, R. Rauck, O. DeLeon, S. Diwan, S. Falowski, Helena Gazelka, P. Kim, M. Leong, Robert Levy, Gladstone II, Porter McRoberts, Ramana Naidu, S. Narouze, C. Perruchoud, S. Rosen, W. Rosenberg, M. Saulino, P. Staats, L. Stearns, Dean Willis, E. Krames, M. Huntoon, N. Mekhail (2017)
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and GuidelinesNeuromodulation: Technology at the Neural Interface, 20
L. Manchikanti, M. Boswell, S. Datta, B. Fellows, S. Abdi, V. Singh, Ramsin Benyamin, F. Falco, S. Helm, S. Hayek, H. Smith (2009)
Comprehensive review of therapeutic interventions in managing chronic spinal pain.Pain physician, 12 4
Denise Wilkes (2014)
Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiencyJournal of Pain Research, 7
Sean Flack, Christine Anderson, C. Bernards (2011)
Morphine Distribution in the Spinal Cord After Chronic Infusion in PigsAnesthesia & Analgesia, 112
AbstractRationale:Intrathecal therapy, with a low complication rate, has become an alternative to standard pain management for treatment of neuropathic cancer pain.Patient concerns:Here, we reported a late-stage cancer patient with intractable neuropathic pain in his right neck, shoulder, and upper limb.Diagnoses:The pain started 2 years ago when the patient was diagnosed as squamous cell carcinoma with metastasis to right supraclavicular lymph nodes.Interventions:Cervical intrathecal infusion of morphine and bupivacaine with patient control analgesia by external pump was performed. The intrathecal catheter was located at the level of C6 vertebra. The initial concentration of bupivacaine and morphine were both 1 mg/mL with infusion rate of 0.3 mL/h and bolus of 0.3 mL. Subsequently, the concentrations increased to 2 mg/mL (bupivacaine) and 1.33 mg/mL (morphine), with infusion rate to 0.6 mL/h and bolus to 0.5 ml.Outcomes:The pain intensity decreased from numerical rating scale 6 to 7 to 2 to 3 at rest, and from 10 to 5 to 6 of breakthrough pain.Lessons:In conclusion, cervical intrathecal infusion requires low concentration but high doses of bupivacaine and morphine, which is safe and effective in cancer patients with refractory pain and short life expectancy.
Medicine – Wolters Kluwer Health
Published: Jan 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.